drugset / Trial / NCT05349435
A Healthy Volunteer Study to Compare Fezagepras (PBI-4050) With Sodium Phenylbutyrate
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to compare the safety, tolerability and pharmacokinetic profile of fezagepras (PBI-4050) to that of sodium phenylbutyrate (PBA) when both products are given as single ascending doses to healthy adult subjects.
Timeline
- Start
- 2022-05-13
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | SETOGEPRAM | Small molecule | — | — |
| Subject | Sodium Phenylbutyrate | Small molecule | — | — |